2-(((Benzyloxy)carbonyl)amino)isonicotinic acid, 98%, 5g

Conjunto de contraste de fase Zernike PLPHi 10/20/40/100 IOS posición de campo claro y campo oscuro

(4-Benzoylpiperidin-1-yl)(3-(2,6-dichlorophenyl)-5-methylisoxazol-4-yl)methanone, 97%, 100mg

tert-Butyl 3-iodo-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carboxylate, 95.0%, 50g

3-Acetyl-5-bromopyridine>97.0%(GC)1g

2,5-Dimethylpyrrolidine, 98%, 1g

1-(2-Cyclopropylthiazol-4-yl)ethan-1-one, 97%, 100mg

3-Benzyloxycarbonylphenylboronic acid, 95.0%, 1g

4-(Pyridin-3-yl)-1H-pyrrole-3-carboxylic acid, 97%, 1g

(3-Fluoro-2-(hydroxymethyl)phenyl)boronic acid, 95.0%, 5g

3-Bromo-4-chloro-5-fluoropyridine, 95.0%, 250mg

cyclohexyl 2,5-dichlorophenyl ketone, 97.0%, 1g

Hexahydrocyclopenta[c]pyrrol-5(1H)-one hydrochloride, 95.0%, 1g